The General Assembly adjourned the 2018 Legislative Session on March 14. Two bills related to opioids that were of concern to pharmacy did not advance. SB 338 would have required the Department of Health to establish a statewide drug takeback program. The bill did not receive a committee hearing. SB 339, which was reported from committee, but not taken up by the full Senate, would have mandated that pharmacists dispense all Schedule II controlled substances in lockable vials. NACDS supported the Indiana Retail Council’s efforts to represent pharmacies’ concerns with both proposals.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.